Netti C, Guidobono F, Sibilia V, Pagani F, Villa I, Pecile A
Department of Pharmacology, Chemotherapy and Medical Toxicology, University of Milan, Italy.
Agents Actions. 1991 May;33(1-2):147-9. doi: 10.1007/BF01993151.
The effects of intracarotid (i.a.) administration of the histamine (HA) H3-receptor agonist (R)-alpha-methyl-histamine (alpha MeHA) and of the H3-antagonist thioperamide, (THIO) on basal or morphine (M)-induced prolactin (PRL) and growth hormone (GH) secretion were studied in male rats. M was administered 3 h after the H3-drugs. Neither THIO (2.5 mg/kg) nor alpha MeHA (10 mg/kg) changed basal PRL levels and only THIO enhanced the PRL-releasing effect of M (6 mg/kg). Basal GH secretion was not modified by THIO. alpha MeHA slightly increased GH secretion. THIO significantly decreased M-stimulated GH secretion (1 mg/kg, i.a.) and alpha MeHA slightly increased it. These results, in agreement with previous evidence obtained after central HA administration, indicated that endogenous brain HA facilitates PRL and inhibits GH secretion.
在雄性大鼠中研究了经颈内动脉(i.a.)注射组胺(HA)H3受体激动剂(R)-α-甲基组胺(αMeHA)和H3拮抗剂硫代哌啶(THIO)对基础或吗啡(M)诱导的催乳素(PRL)和生长激素(GH)分泌的影响。在给予H3药物3小时后给予M。THIO(2.5毫克/千克)和αMeHA(10毫克/千克)均未改变基础PRL水平,只有THIO增强了M(6毫克/千克)的PRL释放作用。THIO未改变基础GH分泌。αMeHA略微增加了GH分泌。THIO显著降低了M刺激的GH分泌(1毫克/千克,i.a.),而αMeHA则使其略有增加。这些结果与先前经中枢给予HA后获得的证据一致,表明内源性脑HA促进PRL分泌并抑制GH分泌。